JP2012526793A5 - - Google Patents

Download PDF

Info

Publication number
JP2012526793A5
JP2012526793A5 JP2012510375A JP2012510375A JP2012526793A5 JP 2012526793 A5 JP2012526793 A5 JP 2012526793A5 JP 2012510375 A JP2012510375 A JP 2012510375A JP 2012510375 A JP2012510375 A JP 2012510375A JP 2012526793 A5 JP2012526793 A5 JP 2012526793A5
Authority
JP
Japan
Prior art keywords
compound
group
alkyl
substituted
unsubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012510375A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012526793A (ja
Filing date
Publication date
Priority claimed from GB0908338A external-priority patent/GB0908338D0/en
Priority claimed from GBGB1006112.5A external-priority patent/GB201006112D0/en
Application filed filed Critical
Priority claimed from PCT/GB2010/050797 external-priority patent/WO2010131054A1/en
Publication of JP2012526793A publication Critical patent/JP2012526793A/ja
Publication of JP2012526793A5 publication Critical patent/JP2012526793A5/ja
Pending legal-status Critical Current

Links

JP2012510375A 2009-05-15 2010-05-17 酸化還元薬物誘導体 Pending JP2012526793A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0908338.7 2009-05-15
GB0908338A GB0908338D0 (en) 2009-05-15 2009-05-15 Redox drug derivatives
GBGB1006112.5A GB201006112D0 (en) 2010-04-13 2010-04-13 Redox drug derivatives
GB1006112.5 2010-04-13
PCT/GB2010/050797 WO2010131054A1 (en) 2009-05-15 2010-05-17 Redox drug derivatives

Publications (2)

Publication Number Publication Date
JP2012526793A JP2012526793A (ja) 2012-11-01
JP2012526793A5 true JP2012526793A5 (cg-RX-API-DMAC7.html) 2013-07-18

Family

ID=42304532

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012510375A Pending JP2012526793A (ja) 2009-05-15 2010-05-17 酸化還元薬物誘導体

Country Status (15)

Country Link
US (1) US8877945B2 (cg-RX-API-DMAC7.html)
EP (1) EP2429991B1 (cg-RX-API-DMAC7.html)
JP (1) JP2012526793A (cg-RX-API-DMAC7.html)
KR (1) KR20120025519A (cg-RX-API-DMAC7.html)
CN (1) CN102459169B (cg-RX-API-DMAC7.html)
AU (1) AU2010247141A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI1010981A2 (cg-RX-API-DMAC7.html)
CA (1) CA2762022A1 (cg-RX-API-DMAC7.html)
EA (1) EA201101564A1 (cg-RX-API-DMAC7.html)
IL (1) IL216214A (cg-RX-API-DMAC7.html)
MX (1) MX2011012134A (cg-RX-API-DMAC7.html)
NZ (2) NZ610978A (cg-RX-API-DMAC7.html)
SG (1) SG176056A1 (cg-RX-API-DMAC7.html)
WO (1) WO2010131054A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201108276B (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2496972A (en) * 2011-11-18 2013-05-29 Redx Pharma Ltd Oxime and hydrazone derivatives of fluoroquinolone antibacterial drugs
GB2498080A (en) * 2011-12-21 2013-07-03 Redx Pharma Ltd Derivatives of oseltamivir
CN102827187B (zh) * 2012-07-18 2014-05-14 河南大学 氟喹诺酮醛缩异烟腙及其制备方法和应用
AU2014265483B2 (en) 2013-05-14 2018-08-02 Biocryst Pharmaceuticals, Inc. Anti-influenza compositions and methods

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1175836A (en) 1977-09-20 1984-10-09 Marcel Pesson Production of 1,4-dihydroquinoline-3-carboxylic acid derivatives
SE444566B (sv) 1977-09-20 1986-04-21 Bellon Labor Sa Roger 7-dialkylamin-6-halogen-4-oxo-1,4-dihydrokinolin-3-karboxylsyra, forfarande for framstellning derav och farmaceutiskt preparat derav
JPS5746986A (en) 1980-09-02 1982-03-17 Dai Ichi Seiyaku Co Ltd Pyrido(1,2,3-de)(1,4)benzoxazine derivative
DE3333719A1 (de) 1983-09-17 1985-04-04 Bayer Ag Loesungen milchsaurer salze von piperazinylchinolon- und piperazinyl-azachinoloncarbonsaeuren
JPH0635458B2 (ja) 1985-02-15 1994-05-11 大日本製薬株式会社 ピリドンカルボン酸誘導体、そのエステルおよびその塩
DK170473B1 (da) 1985-06-20 1995-09-11 Daiichi Seiyaku Co S(-)-pyridobenzoxazinforbindelser
EP0286802B1 (en) 1987-02-26 1993-06-23 Rohto Pharmaceutical Co., Ltd. Use of ofloxacin in treating or preventing locally periodontal disease
JPH07113026B2 (ja) * 1988-06-01 1995-12-06 ダイセル化学工業株式会社 オフロキサシンのエステル類の光学分割方法
DE3906365A1 (de) 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
JP2777661B2 (ja) 1988-10-20 1998-07-23 大塚製薬株式会社 ベンゾヘテロ環化合物
GB8906166D0 (en) 1989-03-17 1989-05-04 Pfizer Ltd Therapeutic agents
SK282950B6 (sk) 1990-04-24 2003-01-09 Biota Scientific Management Pty Ltd Deriváty alfa-D-neuramínovej kyseliny, spôsob ich prípravy, ich použitie a farmaceutické prípravky na ich báze
US6197819B1 (en) 1990-11-27 2001-03-06 Northwestern University Gamma amino butyric acid analogs and optical isomers
NO179912C (no) 1990-11-28 1997-01-08 Daiichi Seiyaku Co Analogifremgangsmåte for fremstilling av et terapeutisk virksomt optisk aktivt pyridobenzoksazinderivat
AU659501B2 (en) 1991-10-23 1995-05-18 Biota Scientific Management Pty Ltd Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-D-neuraminic acid
DE4200414A1 (de) 1992-01-10 1993-07-15 Bayer Ag Chinolon- und naphthyridon-carbonsaeure-derivate
NO304832B1 (no) 1992-05-27 1999-02-22 Ube Industries Aminokinolonderivater samt middel mot HIV
AU673824B2 (en) 1992-05-29 1996-11-28 Bayer Aktiengesellschaft Cyclopentane- and -pentene-beta-amino acids
US5235054A (en) 1992-07-15 1993-08-10 Pfizer Inc. 3-carboxaldehyde substituted quinolines and naphthyridines
DE4234078A1 (de) 1992-10-09 1994-04-14 Bayer Ag Chinoloncarbonsäuren
CA2112165C (en) 1992-12-25 2003-04-08 Makoto Takemura Bicyclic amine derivatives
US5527910A (en) 1992-12-30 1996-06-18 Cheil Foods & Chemicals, Inc. Pyridone carboxylic acid compounds and their uses for treating infectious diseases caused by bacteria
KR0148277B1 (ko) * 1993-01-18 1998-11-02 채영복 신규한 플루오르퀴놀론계 유도체 및 그의 제조방법
DE4301246A1 (de) 1993-01-19 1994-07-21 Bayer Ag Chinolon- und Naphthyridoncarbonsäurederivate
TW301607B (cg-RX-API-DMAC7.html) 1993-03-09 1997-04-01 Takeda Pharm Industry Co Ltd
US5665754A (en) 1993-09-20 1997-09-09 Glaxo Wellcome Inc. Substituted pyrrolidines
CN100409844C (zh) 1995-02-27 2008-08-13 吉里德科学公司 神经氨酸苷酶抑制剂
DE19546249A1 (de) 1995-12-12 1997-06-19 Bayer Ag Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen
US5763483A (en) 1995-12-29 1998-06-09 Gilead Sciences, Inc. Carbocyclic compounds
PL186737B1 (pl) 1996-02-23 2004-02-27 Bayer Ag Kwasy 8-cyjano-1-cyklopropylo-7-/2, 8-diazabicyklo [ 4.3.0 ] nonan-8-ylo/-6-fluoro-1,4-dihydro-4-okso-3-chinolinokarboksylowe i ich pochodne, sposób ich wytwarzania, środki medyczne je zawierające i ich zastosowanie do wytwarzania środków medycznychi antybakteryjnych
US6340702B1 (en) 1996-07-22 2002-01-22 Sankyo Company, Limited Neuraminic acid derivatives, their preparation and their medical use
DK0823428T3 (da) 1996-07-22 2002-02-18 Sankyo Co Neuraminsyrederivater, deres fremstilling og deres medicinske anvendelse
EP0934061B3 (en) 1996-07-24 2015-01-21 Warner-Lambert Company LLC Isobutylgaba and its derivatives for the treatment of pain
KR20000068986A (ko) 1996-11-14 2000-11-25 리차드웨드레이 신규 용도 화합물 및 그 제조방법
US6127418A (en) 1997-08-20 2000-10-03 Warner-Lambert Company GABA analogs to prevent and treat gastrointestinal damage
TW477783B (en) 1997-12-12 2002-03-01 Gilead Sciences Inc Novel compounds useful as neuraminidase inhibitors and pharmaceutical compositions containing same
PT1040094E (pt) 1997-12-17 2009-06-03 Biocryst Pharm Inc Compostos de ciclopentano e de ciclopenteno substituídos úteis como inibidores da neuraminidase
HN1999000174A (es) 1998-10-30 1999-10-13 Bayer Ag Formulacion medicamentosa acuisa para administracion oral.
DE19941217A1 (de) 1999-08-30 2001-03-15 Asta Medica Ag Behandlung der Migräne durch Verabreichung von alpha-Liponsäure oder Derivaten derselben
AU3223801A (en) 2000-02-09 2001-08-20 Daiichi Seiyaku Co Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredient
JP2004099494A (ja) 2002-09-09 2004-04-02 Shiono Chemical Co Ltd 光学活性三環式化合物の製造方法
WO2005033108A1 (en) 2003-09-22 2005-04-14 Janssen Pharmaceutica, N.V. 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
DE602005009195D1 (de) 2004-06-23 2008-10-02 Robert F Hofmann Verwendung einer gezielten oxidativen therapeutischen formulierung bei der behandlung von verbrennungen
EP1986636B1 (en) 2006-02-22 2013-04-24 Edison Pharmaceuticals, Inc. Phenol and 1,4-benzoquinone derivatives for use in the treatment of mitochondrial diseases
EP2017273A1 (en) 2007-07-18 2009-01-21 Laboratorios del Dr. Esteve S.A. Process for the enantioselective preparation of pregabalin
CN101883569B (zh) 2007-08-31 2013-08-21 梁启铭 具有抗流感活性之含奥司他伟膦酸酯同系物的合成
EP2053040A1 (en) 2007-10-26 2009-04-29 Chemo Ibérica, S.A. Pregabalin intermediates and process for preparing them and Pregabalin

Similar Documents

Publication Publication Date Title
JP2015505296A5 (cg-RX-API-DMAC7.html)
JP2016506960A5 (cg-RX-API-DMAC7.html)
JP2014508804A5 (cg-RX-API-DMAC7.html)
JP2016528301A5 (cg-RX-API-DMAC7.html)
JP2016505512A5 (cg-RX-API-DMAC7.html)
JP2013518107A5 (cg-RX-API-DMAC7.html)
JP2015500843A5 (cg-RX-API-DMAC7.html)
JP2015512931A5 (cg-RX-API-DMAC7.html)
JP2017531038A5 (cg-RX-API-DMAC7.html)
JP2020097577A5 (cg-RX-API-DMAC7.html)
JP2013507423A5 (cg-RX-API-DMAC7.html)
JP2011246469A5 (cg-RX-API-DMAC7.html)
JP2016534063A5 (cg-RX-API-DMAC7.html)
JP2017508782A5 (cg-RX-API-DMAC7.html)
JP2017537066A5 (cg-RX-API-DMAC7.html)
JP2015508103A5 (cg-RX-API-DMAC7.html)
JP2018524390A5 (cg-RX-API-DMAC7.html)
JP2012092103A5 (cg-RX-API-DMAC7.html)
JP2011529054A5 (cg-RX-API-DMAC7.html)
JP2020507589A5 (cg-RX-API-DMAC7.html)
JP2011518833A5 (cg-RX-API-DMAC7.html)
JP2016040288A5 (cg-RX-API-DMAC7.html)
JP2016503797A5 (cg-RX-API-DMAC7.html)
JP2012512863A5 (cg-RX-API-DMAC7.html)
JP2015051983A5 (cg-RX-API-DMAC7.html)